CLARIVATE ($CLVT) posted quarterly earnings results for Q4 2025 on Tuesday, February 24th. The company reported earnings of $0.20 per share, beating estimates of $0.17 by $0.03. The company also reported revenue of $617,000,000, beating estimates of $616,932,862 by $67,138.
You can see Quiver Quantitative's $CLVT stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
CLARIVATE Insider Trading Activity
CLARIVATE insiders have traded $CLVT stock on the open market 5 times in the past 6 months. Of those trades, 4 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $CLVT stock by insiders over the last 6 months:
- ANDREW MILES SNYDER purchased 1,460,000 shares for an estimated $4,861,800
- KENNETH L. CORNICK has made 3 purchases buying 825,000 shares for an estimated $2,827,000 and 0 sales.
- BAR VEINSTEIN (President, A&G) sold 309,902 shares for an estimated $1,159,033
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
CLARIVATE Hedge Fund Activity
We have seen 114 institutional investors add shares of CLARIVATE stock to their portfolio, and 131 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- HG VORA CAPITAL MANAGEMENT, LLC removed 11,125,000 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $37,157,500
- PERPETUAL LTD removed 8,567,267 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $28,614,671
- ATAIROS PARTNERS GP, INC. added 6,767,667 shares (+195.3%) to their portfolio in Q4 2025, for an estimated $22,604,007
- IMPACTIVE CAPITAL LP removed 6,611,339 shares (-15.4%) from their portfolio in Q4 2025, for an estimated $22,081,872
- FIRST TRUST ADVISORS LP added 5,006,183 shares (+inf%) to their portfolio in Q4 2025, for an estimated $16,720,651
- BALYASNY ASSET MANAGEMENT L.P. removed 4,482,113 shares (-91.8%) from their portfolio in Q4 2025, for an estimated $14,970,257
- NORGES BANK removed 4,481,984 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $14,969,826
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
CLARIVATE Analyst Ratings
Wall Street analysts have issued reports on $CLVT in the last several months. We have seen 0 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- Morgan Stanley issued a "Underweight" rating on 12/17/2025
To track analyst ratings and price targets for CLARIVATE, check out Quiver Quantitative's $CLVT forecast page.
CLARIVATE Price Targets
Multiple analysts have issued price targets for $CLVT recently. We have seen 2 analysts offer price targets for $CLVT in the last 6 months, with a median target of $3.3.
Here are some recent targets:
- George Tong from Goldman Sachs set a target price of $3.6 on 01/08/2026
- Toni Kaplan from Morgan Stanley set a target price of $3.0 on 12/17/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
